Ann Arbor Firm Develops Conductive Coating to Improve Cardiac, Other Procedures


Ann Arbor-based Biotectix announced today a new conductive coating for medical devices they say will maximize both efficiency and safety during a cardiac or nervous system procedure.

The use of the electro-conductive coating ultimately results in greater tissue-sensing resolution and more localized stimulation control, thereby enhancing communication between human tissue and a medical device’s electrode, says Sarah Richardson-Burns, who co-founded Biotectix with Jeff Hendricks.

The end result is that the technology helps surgeons make smaller, less invasive examinations and procedures.

“Amplicoat is a true breakthrough technology that provides a durable electrode coating that conducts both ionically and electronically, resulting in lower impedance and an expanded range for safe charge delivery,” Richardson-Burns says.

The coating can be applied to a variety of metal electrodes, providing a solution for numerous medical-device applications, including neurostimulation, cardiac pacing, electrophysiology recordings, cochlear implants, and gastrointestinal recording and stimulation.

Biotectix is working with medical manufacturers to incorporate Amplicoat into their devices. Non-medical applications for the coating are currently under development.